Papadea Christine, Foster Joyce, Grant Sharon, Ballard Sandra A, Cate John C, Southgate W Michael, Purohit Dilip M
Department of Pathology, Medical University of South Carolina, Charleston 29425, USA.
Ann Clin Lab Sci. 2002 Summer;32(3):231-43.
We evaluated the analytical performance of the i-STAT Portable Clinical Analyzer (PCA), a point-of-care testing system consisting of a hand-held analyzer and single-use cartridges that measure different panels of electrolytes, metabolites, blood gases, and hematocrit in 65-100 microl of blood. Our objective was to determine whether PCA measurements at the bedside of patients in the neonatal and pediatric intensive care units of the MUSC Children's Hospital would be as reliable as those performed by the clinical laboratory's primary methods (Radiometer ABL 725 blood gas analyzer; Vitros 750 chemistry analyzer; and Coulter STKS hematology analyzer). Four cartridge types: (a) EC8+ (sodium; potassium; chloride; urea; glucose; pH; blood gases [PO2; pCO2]), (b) EC6+ (sodium; potassium; ionized calcium; glucose; hematocrit; pH), (c) G3+ (pH; PO2; pCO2), and (d) creatinine, were assessed for reproducibility, linearity, and method comparisons using aqueous samples, blood samples supplemented with several analytes, and -225 blood samples from patients. Reproducibility (CV) was good (< 2%) for electrolytes, glucose, urea, and pH, satisfactory (< 6.5%) for blood gases and creatinine, but poor (21%) for hematocrit. Linearity concentrations spanning the clinically relevant ranges were verified for all analytes. Method comparison studies with samples separated into 2 subgroups by patient age (> or < 3 mo) showed that agreement between the PCA and the primary methods was clinically acceptable. After the PCA was implemented for clinical testing, the observation of discrepant results of creatinine concentrations in neonatal blood samples that would have affected clinical management led to a second creatinine comparison study (59 additional samples) and to our eventual discontinuation of the PCA creatinine assay. This problem notwithstanding, the successful implementation of the PCA is attributed to careful analytical evaluations and ongoing communication with the clinical staff.
我们评估了i-STAT便携式临床分析仪(PCA)的分析性能,这是一种即时检验系统,由手持式分析仪和一次性检测卡组成,可在65至100微升血液中测量不同组别的电解质、代谢物、血气和血细胞比容。我们的目标是确定在南卡罗来纳医科大学儿童医院新生儿和儿科重症监护病房的患者床边进行的PCA测量是否与临床实验室的主要方法(Radiometer ABL 725血气分析仪;Vitros 750化学分析仪;以及库尔特STKS血液学分析仪)所进行的测量一样可靠。评估了四种检测卡类型:(a)EC8 +(钠、钾、氯、尿素、葡萄糖、pH值、血气[PO2、pCO2]),(b)EC6 +(钠、钾、离子钙、葡萄糖、血细胞比容、pH值),(c)G3 +(pH值、PO2、pCO2),以及(d)肌酐,使用水性样本、添加了几种分析物的血液样本和来自患者的225份血液样本进行了重复性、线性和方法比较评估。电解质、葡萄糖、尿素和pH值的重复性(CV)良好(<2%),血气和肌酐的重复性令人满意(<6.5%),但血细胞比容的重复性较差(21%)。验证了所有分析物在临床相关范围内的线性浓度。对按患者年龄(>或<3个月)分为两个亚组的样本进行的方法比较研究表明,PCA与主要方法之间的一致性在临床上是可以接受的。在PCA用于临床检测后,观察到新生儿血液样本中肌酐浓度的差异结果可能会影响临床管理,这导致了第二项肌酐比较研究(另外59份样本),并最终导致我们停止了PCA肌酐检测。尽管存在这个问题,但PCA的成功实施归功于仔细的分析评估以及与临床工作人员的持续沟通。